Avidity Biosciences (RNA US)

Analysis

Health Care • United States

Avidity Biosciences LLC operates as a biotechnology company. The Company develops and discovers novel antibody oligonucleotide conjugates therapeutics that overcome current barriers to the delivery of oligonucleotides and unlock their potential to treat a wide range of serious diseases. Avidity Biosciences serves customers in the United States.

Refresh

Company Presentation • 19 May 2021 19:00

Investor Presentation

Company Presentation • 02 Aug 2021 20:30

Status Update

Company Presentation • 10 Dec 2021 00:00

Status Update

Company Presentation • 13 Oct 2022 22:00

Study Update

Company Presentation • 03 Oct 2022 22:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00